We previously reported that resistance to the induction of adjuvant arthritis after preimmunization with mycobacterial hsp60 was mediated by T cells recognizing a conserved epitope (M256-270) of mycobacterial hsp60. These T cells were cross-reactive with the homologous rat hsp60 peptide sequence and the natural self-epitope on stressed antigen-presenting cells. Recognition of peptide M256-265, the conserved core of peptide M256-270, was shown to be essential for the generation of self-reactive T cells. The rat homologue of peptide M256-265, peptide R256-265, differs with three conservative amino acid substitutions from the mycobacterial core peptide. Thus peptide R256-265 could act as an altered peptide ligand with the potential of inducing a different functional phenotype in M256-270-specific T cells. We now show that peptide R256-265 was recognized by M256-270-specific T cells as a partial agonist, inducing TCR down-regulation and up-regulation of activation/adhesion molecules in the absence of proliferative responses. Peptide R256-265 did not induce anergy but induced B7-2 (but not B7-1) expression on M256-270-specific T cells, as opposed to the mycobacterial peptide, which preferentially induced B7-1. These effects were more pronounced at low peptide concentrations. Therefore also in vivo at the more relevant low physiological level of expression, the self-hsp could induce such phenotype. It is discussed how this selective up-regulation of B7-2 expression on (self-hsp60) autoreactive T cells might be a way by which destructive autoimmune responses are controlled.
Introduction
The functional outcome of TCR triggering, inherent to the antigen acting as altered peptide ligands (APL) generating a low-avidity interaction (reviewed in 1). quality of TCR signaling (1,2), can be a major determinant of self-responsiveness or self-non-responsiveness. Self-reactive For hsp60 as a self-antigen, evidence in favor of positive selection was obtained in a transgenic mouse model where T cells have been shown to be part of the normal healthy immune repertoire (3,4). These T cells, after having been mouse hsp60 was overexpressed using the MHC class II promoter, leading to abundant thymic expression in conjuncpositively selected in the thymus based on recognition of thymic self, have passed negative selection on the basis of tion with an increased peripheral T cell reactivity (5). Also, other groups described the presence of cross-reactive T cells sub-threshold avidity of their TCR-MHC-self-antigen complex interaction. In various studies it was suggested that the recognizing self-hsp60-derived peptides and their mycobacterial homologues in the periphery, indicating that tolerance positive selection of this population of low-avidity T cells had occurred, in fact, on the basis of the positively selecting selffor this self-antigen was not complete (6-9). In addition, the inherent degeneracy of TCR recognition (7, 10) would easily and contained an amide group at the C-terminus. Peptides were checked by reversed-phase HPLC and by fast atom jeopardize self/non-self discrimination, especially in the case of conserved proteins like heat shock proteins, given the fact bombardment mass spectrometry. that bacterial heat shock proteins are amongst the most MHC binding assay immunogenic proteins present in microbial organisms (11, 12) . Also, mechanisms described for inducing and maintaining
The MHC-peptide binding assay studies were performed active peripheral tolerance to self-antigens present in the using a direct binding assay as described (27) . Briefly, Rat periphery are held to be related to the quality of TCR signaling, RT1.B l molecules were affinity purified from cell lysates of the and such mechanisms can lead to the induction of selfconcanavalin A-activated MHC class II ϩ Z1a T cell clone reactive T cells which are rather regulatory than pathogenic.
using the mAb OX6 coupled to Sepharose-4B beads. For These latter mechanisms include the induction of anergy competition studies purified MHC class II molecules (2 µM) (13, 14) , generation of IL-10 (T r 1) (15, 16) and/or transforming were incubated with 200 nM of biotinylated peptide myelin growth factor-β producing cells (T h 3) (17) or a switch from basic protein (MBP) 72-85 and a dose range (0-256 µM) of T h 1-to T h 2-type responses resulting in immune deviation (18) .
competitor peptides for 40 h at room temperature and pH 5 In the case of self-hsp60-reactive T cells, expansion of in the presence of a protease inhibitor mix. The MHC-T cells recognizing a conserved epitope of Mycobacterium peptide mixtures were analyzed via non-reducing SDS-PAGE, tuberculosis hsp60 (M256-270) induced resistance to active followed by Western blotting (Hybond-ECL; Amersham, Little disease in the models of adjuvant arthritis (AA) and avridineChalfont, UK). Biotinylated peptides were visualized on preinduced arthritis (19) (20) (21) . These T cells were cross-reactive flashed films (Hyperfilm; Amersham), through enhanced in recognizing the corresponding rat homologue peptide chemiluminescence (Western Blot ECL kit; Amersham). Spots R256-270 and this cross-reactivity was restricted to T cells on the films were quantified by image processing. specific for the conserved mycobacterial core-peptide M256-265 (21) (Paul et al., submitted). As in vivo these T cells
Generation of peptide-specific T cell lines may see the self-antigen (over-)expressed at the surface of Rats were lightly anesthetized using ether and immunized stressed cells at sites of inflammation or at sites of immune with 50 µg of synthetic peptide in 50 µl PBS/DDA in each activation (22) (23) (24) , it is possible that this leads to activation hind footpad (i.e. 100 µg/rat). Ten days later, draining popliteal of such cells. If so, the resulting inhibition of disease developlymph nodes were removed, disaggregated, washed twice ment could be a consequence of the quality of TCR signaling and used as a source of primed lymph node cells (PLNC). induced by the self-antigen, producing a regulatory functional T cell lines were generated by culturing PLNC at 5ϫ10 -6 /ml phenotype in these self-responsive T cells. In this study in culture medium (IMDM; Gibco/BRL, Gaithersburg, MD) plus we therefore tested the functional phenotype of M256-270-2 mM L-glutamine, 100 U/ml penicillin, 100 µg/ml streptomycin specific T cells upon recognition of the rat homologue of the (Gibco/BRL) and 5ϫ10 -5 M 2-mercaptoethanol) supplecore-epitope M256-265, peptide R256-265. We found this mented with 2% naive inactivated rat serum (NRS) in the peptide to be recognized as a partial agonist, that skews the presence of 10 µg/ml peptide. After 3 days, viable cells were cytokine profile in the direction of a T h 2 phenotype and harvested using a Ficoll-Isopaque gradient and expanded for that induces the preferential expression of B7-2 and down-4 days in culture medium supplemented with 10% EL-4 modulates the expression of LFA-1 on M256-270-specific supernatant (as a source of IL-2) and 10% FCS. Seven days T cells. As we previously described that M256-270-specific after initial stimulation, 4ϫ10 5 T cells/ml were re-stimulated T cells inhibit the development of AA (21), we suggest that with 1ϫ10 6 /ml irradiated (3000 rad) syngeneic splenocytes the B7-2 expression on T cells cross-reactive with self-hsp as a source of APC and 10 µg/ml peptide in culture medium might be involved in the regulation of AA.
supplemented with 2% NRS. Lines were maintained in this 7 day re-stimulation cycle. The M256-270-specific T cell lines were generated by immunization and re-stimulation with pep- Induction of anergy in the presence of APC 100 µg/ml) of peptides M256-265 or R256-265, or medium alone in the presence of APC under the conditions described M256-270-specific T cells (4ϫ10 5 /ml) were incubated for above for lymphocyte proliferation assays. For detection of 20-24 h with 2ϫ10 6 /ml APC in culture medium supplemented cytokine mRNA levels, RT-PCR analysis was performed. Total with 2% NRS and 10 or 100 µg/ml of peptide in a six-wells plate RNA was isolated from cell pellets by extraction with RNAzol (Costar). As a control, only culture medium supplemented with (Gibco/BRL). The isolated RNA and 0.5 µg oligo(dT) [12] [13] [14] [15] [16] [17] [18] was 2% NRS was added. After 20-24 h, viable T cells were heated at 55°C for 10 min and cooled to room temperature. collected by Ficoll-Isopaque gradient centrifugation and culFirst strand synthesis was performed by incubating 1 µg RNA tured additionally for 3 days in culture medium supplemented in a reaction mixture (total volume 20 µl) containing 5 mM with 2% NRS at 4ϫ10 5 /ml. Viable T cells were then recovered Tris-HCl, pH 8.3 at 42°C, 50 mM KCl, 10 mM MgCl 2, 2 mM by Ficoll-Isopaque gradient centrifugation and tested in a dithiothreitol, 1 mM of dATP, dCTP, dGTP and dTTP each, lymphocyte proliferation assay as described above.
and 25 U reverse transcriptase. The mixture was incubated Flow-cytometry at 42°C for 1.5 h. The mixture was cooled on ice and diluted Expression of cell-surface molecules on M256-270-specific 6 times in H 2 O. cDNA was incubated in a mixture (total T cells was analyzed after 20-24 h of incubation in the volume of 20 µl) containing 0.1 mM of dATP, dCTP, dGTP and presence of irradiated splenocytes as APC, as described dTTP each, 50 mM KCl, 10 mM Tris-HCl, pH 9.0 at 25°C, above for induction of anergy with a few modifications. APC 1.5 mM MgCl 2 , 0.01% gelatin, 0.1% Triton X-100, 50 ng of were first labeled with 2Ј,7Ј-bis-(carboxyethyl)-5(6)-carboxythe desired 5Ј and 3Ј primers each, and 0.625 U Taq DNA fluorescein acetoxymethyl ester [BCECF-AM; Boehringer polymerase I (Perkin-Elmer, Nieuwerkerk aan den Ussel, The Mannheim, Almere, The Netherlands; measured in the FL1-Netherlands). The mixture was subjected to 2 min of 94°C, channel of a FACScan] by incubating 1ϫ10 7 splenocytes/ml followed by 35 cycles of 10 s at 94°C, 30 s at 60°C and 30 for 20 min at 37°C, 5% CO 2 atmosphere, with 0.1 µM BCECFs at 72°C, followed by 10 min at 72°C, in a PCR apparatus AM. After washing 3 times, APC were pulsed with different (9600; Perkin-Elmer). For detection of IL-4 mRNA, a nested concentrations (1, 10 or 100 µg/ml) of peptides M256-265 or PCR was performed with a first amplification for 35 cycles R256-265 by incubating 1.3ϫ10 7 APC/ml for 1.5 h with with full-length primers followed by a second amplification for peptide at 37°C, 5% CO 2 . After washing twice, 4ϫ10 5 M256-25 cycles with nested primers. PCR products were visualized 270-specific T cells/ml in culture medium supplemented with on a 2% ethidium bromide-stained agarose gel. The following 2% NRS were added 7 days after the last re-stimulation to rat-specific primer pairs were used: G3PDH (452 bp frag-2ϫ10 6 /ml labeled APC in a six-well plate (Costar). ment): 5Ј-ACC ACA GTC CAT GCC ATC AC, 3Ј-TCC ACC After 20-24 h of incubation following the protocol described ACC CTG TTG CTG TA; IL-4 (first PCR round 460 bp fragment, above, viable cells were collected by Ficoll-Isopaque gradient including XbaI-BamHI restriction sites as indicated in small centrifugation, and washed twice with culture medium, type): 5Ј-CCg gat ccA TGG GTC TCA GCC CCC ACC T, 3Ј-counted and reconstituted to 4ϫ10 5 cells/ml. Cells were GCt cta gaT TAG GAC ATG GAA GTG CAG GAC T and for washed once with FACS buffer (PBS containing 1% BSA and nested PCR (238 bp fragment): 5Ј-ATG CAC CGA GAT GTT 0.1% NaN 3 and 4% NRS) and incubated for 30 min on ice at TGT ACC, 3Ј-TTT CAG TGT TCT GAG CGT GGA; IL-10 (127 1:2 in FACS buffer diluted mouse-anti-rat specific cell-surface bp fragment): 5Ј-TGC CAA GCC TTG TCA GAA ATG ATC marker. Cells were washed twice and incubated for 30 min AAG, 3Ј-GTA TCC AGA GGG TCT TCA GCT TCT CTC; IFN-γ at 1:300 in FACS buffer-diluted phycoerythrin (PE)-conjugated (419 bp fragment): 5Ј-CCC TCT CTG GCT GTT ACT GC, 3Ј-goat anti-mouse total IgG antibody (PharMingen). Cells were CTC CTT TTC CGC TTC CTT AG. washed twice and resuspended in FACS buffer without NRS. Residual dead cells were excluded based on the FSC/SSC by raising the threshold on FSC and the PE fluorescence of Results the T cell population was measured in the FL2-channel of a FACScan (Becton Dickinson, Mountain View, CA) after gating Analysis of the proliferative response of mycobacterial M256-on the FL1-negative population (when incubated with BCECF-270 peptide-reactive T cells AM-labeled APC). Data were analyzed using CellQuest soft-A T cell line specific for peptide M256-270 was generated ware (Becton Dickinson). The following mAb were used: IgG1 from M256-270 immunized Lewis rats (see Methods) and isotype mAb: R73 (anti-TCR β), W3/25 (anti-CD4), OX39 (antiused after three cycles of in vitro re-stimulation. To investigate CD25 or anti-IL2R ), 3H5 (anti-CD80 or B7-1), 24F (anti-CD86 the fine specificity of the cross-recognition of self-hsp60 by or B7-2), IA29 (anti-CD54 or ICAM-1); IgG2a isotype mAb:
the mycobacterial M256-270-specific T cells we tested the WT.1 (anti-CD11a or LFA-1); IgG2b isotype mAb: OX40 (antiproliferative responses upon stimulation with a dose range of CD134 or OX40 antigen). Isotype control mAb were UD15 the mycobacterial peptide M256-270, the mycobacterial core [IgG1, anti-choramphenicol (28)] and IE7.4H11 [IgG2a, antipeptide M256-265 and the rat homologue R256-265 (see ovine IgE (29)]; for IgG2b no isotype control mAb was Methods for peptide sequences). The mycobacterial core available, therefore only secondary antibody served as conpeptide M256-265 induced high proliferative responses, simtrol. R73 was a kind gift from Professor T. Hunig; 3H5 and ilar to responses seen with the mycobacterial peptide M256-24F hybridomas were kind gifts from Dr H. Yagita. 270, the antigen used for generation of the responder T cell Cytokine analysis line (Fig. 1) . Stimulation with the rat homologue R256-265, however, did not induce significant proliferative responses To assess the cytokines produced by the M256-270-specific T cells, they were stimulated with a dose range (0.1-(Ͻ2 times background) at all the concentrations tested (0.1- sequence between M256-265 and the rat homologue R256-265 (see Methods), which might alter the MHC class II binding, we tested peptides M256-270, M256-265 and R256-265 in a MHC binding assay. Figure 2 shows that the 15mer been incubated with non-pulsed APC (Fig. 3) . The amount of up-regulation of the IL-2 receptor, OX40 and ICAM-1 upon peptide M256-270 had a similar binding affinity to RT1.B l as the 10mer mycobacterial core peptide M256-265, as reflected stimulation with peptide R256-265 was less than that seen upon stimulation with peptide M256-265, which induced high in their IC 50 values (25 µM). Thus binding in this case was not influenced by using a shorter peptide. Also, peptide proliferative responses. However, the level of TCR downregulation was similar upon stimulation with peptides M256-R256-265 was found to have binding affinity for RT1.B l although binding was reduced 5-fold (IC 50 ϭ 125 µM) com-265 and R256-265 (Fig. 3) . Up-regulation of the IL-2 receptor/ OX40 and down-regulation of the TCR was also found with pared to peptides M256-270 and M256-265, which indicated that the changes in amino acid residues affected binding to lower doses of peptide R256-265 (1-10 µg/ml; data not shown). MHC class II. None of the peptides showed binding to RT1.D l (data not shown).
Expression of CD4 and VLA-4 was not altered upon stimulation with peptides M256-265 or R256-265 compared to T cells Peptide R256-265 induces down-regulation of the TCR and incubated with non-pulsed APC. Expression of MHC class II up-regulation of activation markers molecules RT1.B l and D l was slightly up-regulated by R256-265, whereas peptide M256-265 induced a more pronounced As the absence of proliferative responses does not preclude other forms of T cell activation, we tested the ability of the rat up-regulation. The modulation of cell-surface markers upon stimulation with the longer mycobacterial peptide M256-homologue R256-265 to modify the expression of activationmarkers on M256-270-specific T cells after stimulation with 270 was similar to that found with peptide M256-265 (data not shown). peptide-pulsed (100 µg/ml) APC. As a control we tested T cells incubated with non-pulsed APC. Viable T cells were
The rat homologue peptide R256-265 does not induce unrecollected after 20-24 h of incubation and analyzed for expressponsiveness sion of cell-surface molecules.
Similar to peptide M256-265, peptide R256-265 induced As the sequence of the rat homologue peptide R256-265 differed slightly from the mycobacterial peptide M256-a 2-to 3-fold down-regulation of TCR expression (Fig. 3) as well as down-regulation of CD3 (data not shown). Moreover, 265 (see Methods), we investigated whether peptide R256-265 could act as an anergy-inducing APL for M256-peptides M256-265 and R256-265 induced a significant upregulation of the IL-2 receptor and up-regulation of the 270-specific T cells. Therefore M256-270-specific T cells were incubated with peptide M256-270 or with peptide R256-adhesion molecule ICAM-1. Also, the expression of OX40 antigen was up-regulated compared to T cells which had 265 in the presence of APC. T cells incubated with APC only served as a control. After 20-24 h of incubation, viable T cells were collected and maintained in culture for 3 days in the absence of IL-2 in order to allow re-expression of TCR-CD3. Subsequently proliferative responses to peptide M256-270 in the presence of freshly added APC were examined. Figure 4 shows that a supraoptimal dose (100 µg/ml) of peptide M256-270 induced unresponsiveness. The unresponsiveness induced was not the result of a decreased viability, as concanavalin A and IL-2 responses were found to be similar to those of T cells which did not become unresponsive (Fig. 4) . Furthermore this was not due to a down-regulation of the TCR-CD3, since after 3 days of culturing expression levels were similar to T cells incubated with APC only (data not shown). In contrast to this, peptide R256-265 did not induce unresponsiveness in M256-270-specific T cells at peptide concentrations of 100 or 10 µg/ml (Fig. 4) . Also, we found no differences in the IL-2 production, upon rechallenge with tide R256-265 preferentially induced B7-2 expression and not B7-1. A similar tendency was seen after presentation of peptide R256-265 in the absence of APC (T-T presentation; data not shown).
Discussion
Previously we showed that preimmunization with a conserved peptide of mycobacterial hsp60 (M256-270) induced resistance to active disease in the model of AA and avridineinduced arthritis. This resistance was possibly mediated by induction of cross-reactive T cells recognizing self-hsp60 (21) . However, the mode of action of the resistance producing to mechanisms of peripheral tolerance (reviewed in 30,31) or columns 2-5, respectively 1, 5, 25 and 100 µg/ml M256-265; columns 6-9, respectively 0.1, 1, 5 and 25 µg/ml R256-265. ND, not they can be mediators of peripheral tolerance (32-36). As determined.
the self-hsp60-reactive T cells were capable of adoptively transferring their protective effect, they can be such mediators of peripheral tolerance themselves. Since the amino acid sequences of the rat and mycobacterial hsp60 peptide In contrast, stimulation with peptide R256-265 induced a different pattern, i.e. a peptide concentration-dependent differed slightly, the rat peptide R256-265 could be seen as an APL (1). APL can induce T cell responses that differ decrease in the induction of IFN-γ and (less clearly) IL-10 mRNA (Fig. 5, columns 6-9 ) compared to the levels produced qualitatively from wild-type peptide-induced responses (2,37). Amongst these are peripheral tolerance-promoting functional upon stimulation with APC only (Fig. 5, column 1) . Interestingly, stimulation with low concentrations of peptide R256-265 phenotypes such as anergy or T cells producing anti-inflammatory cytokines (38-42). Therefore self-derived peptides, induced IL-4 mRNA and this effect was lost at higher peptide concentrations.
when recognized as APL, may be able to mediate peripheral tolerance by means of these mechanisms. As expected by the lack of proliferation, stimulation with peptide R256-265 did not induce IL-2, whereas upon stimulaFirst of all, we determined if the differences in amino acid sequence between the mycobacterial peptide and its rat tion with peptide M256-265 and M256-270, IL-2 was produced in a peptide dose-dependent manner (data not shown).
homologue affected MHC binding. The self-peptide R256-265 was found to have a 5-fold lower MHC-binding affinity as Peptide R256-265 down-regulates LFA-1, and preferentially compared to its mycobacterial homologue M256-265. This induces B7-2 and not B7-1 was compatible with earlier observations that most peptides inducing autoreactive T cells were relatively weak MHC Subsequently we investigated whether the activation of M256-270-specific T cells by peptide R256-265, which did not elicit binders (43). Due to a resulting low-avidity interaction with the TCR these T cells may have escaped negative selection proliferative responses, led to a differential expression of cellsurface markers. (44, 45) , explaining their presence in the repertoire. However, despite a 5-fold lower MHC-binding affinity, we found that When we analyzed the expression of the adhesion molecule LFA-1 (CD11a) on M256-270-specific T cells we found that proliferative responses could not be induced with peptide R256-265 even with a 10-to 100-fold increase in antigen peptide M256-265 up-regulated LFA-1 expression (Fig. 6a,  upper panel) , whereas peptide R256-265 induced a downconcentration compared to the mycobacterial homologue (Fig. 1) . This indicated the presence of differences in TCR regulation of LFA-1 (Fig. 6a, lower panel) . This down-regulation was also found for lower doses (1-10 µg/ml) of peptide R256-contact residues, in addition to differences in MHC contact residues, between peptide R256-265 and peptide M256-265 (data not shown).
When analyzing the cell-surface expression of B7-1 and 265, and the ability of the rat homologue to be recognized as an APL. That peptide R256-265 was indeed recognized as B7-2 after stimulation with peptide R256-265 or M256-265 we found that peptide M256-265, which was able to induce an APL was shown by the absence of proliferative responses accompanied by TCR-CD3 down-regulation and profound proliferative responses, up-regulated B7-1 and B7-2 in a dose-dependent manner (Fig. 6b and c, left panels) . No upup-regulation of activation markers, as also described by others (38,46). Therefore we determined if peptide R256-265 regulation of B7-1 was seen upon stimulation with peptide R256-265 at all concentrations (Fig. 6b, right panel) . However, could induce a functional phenotype capable of promoting peripheral tolerance. First we tested its ability to induce B7-2 was up-regulated after stimulation with R256-265 (Fig. 6c, right panel) . In contrast to the dose-dependent anergy in the presence of APC (38). Preincubation with a high dosage of the wild-type peptide M256-270 induced increase found with peptide M256-265, B7-2 expression was maximal at a peptide concentration of 1 µg/ml and decreased unresponsiveness, possibly reflecting a post-activation refractory period. However, under the test conditions as used at higher peptide concentrations. Thus stimulation with pep- for inducing anergy by APL (38), peptide R256-265 did not induce anti-inflammatory cytokines in M256-270-specific T cells. We found that, compared to peptide M256-265, the induce anergy. Thus our in vitro data were not supportive of an anergy-inducing mechanism in our self-hsp60-specific self-peptide did not up-regulate IL-2, IFN-γ or IL-10 but still induced low levels of IL-4. Thus, although peptide R256-265 T cells, upon encountering self-hsp60 in vivo, to account for the protective effect of these T cells in arthritis. However, we did not induce the production of cytokines other than induced by the mycobacterial homologue, stimulation with this peptide cannot exclude that this mechanism might occur in vivo by, for instance, the recognition of self-hsp60 on non-professional led to a relative skewing towards a T h 2 phenotype. As peptide R256-265 had a lower MHC-binding affinity, described to APC (13, 47) or by a more continuous engagement of the TCR (48) .
preferentially induce a T h 2-phenotype (49-51), this could have accounted for our observed induction of IL-4. However, Secondly, we determined whether peptide R256-265 could this seems unlikely, as peptide M256-265 which had a higher our finding of decreased LFA-1 expression upon stimulation with peptide R256-265. MHC binding affinity, also induced IL-4. Higher concentrations of peptide R256-265 inhibited the production of IL-4, IL-10
Thus, in the case of T cells recognizing self-hsp60 as an APL, they can discriminate between self or non-self by and IFN-γ in contrast to the induction of these cytokines by the mycobacterial peptide M256-265. Thus, it argues more detecting qualitatively distinct signals through the TCR. Importantly, such APL-like recognition of self might lead to a for a qualitatively different TCR signal induced by peptide R256-265 rather than the effects being related to a reduced potential regulatory phenotype which could well be triggered in vivo upon recognition of self-hsp60 on cells leading to amount of MHC-peptide complexes.
Further analysis of cell-surface markers revealed that pepdown-modulation of pathogenic T cells. In particular, upregulation of activation markers, down-regulation of the TCR/ tide R256-265 preferentially induced the expression of B7-2 on M256-270-specific T cells. This was not seen for peptide LFA-1, and induction of the anti-inflammatory cytokines IL-4 and IL-10 together with the induction of B7-2 were observed M256-265 (Fig. 6c) . At all the concentrations tested peptide R256-265 did not induce the expression of B7-1 on M256-at those (low) peptide concentrations of R256-265 which may be physiologically relevant. Therefore, this ability of a self-270-specific T cells, in contrast to that seen upon stimulation with peptide M256-265 (Fig. 6b) . So far no data on the hsp60 peptide to be recognized as an APL not only can promote positive selection of these self-reactive T cells in the differential expression of B7-1 and B7-2 on T cells after activation with altered peptides or self-epitopes have been thymus, but may also ensure that upon recognition in the periphery these T cells are tolerized into a regulatory mode, described. However, several reports suggested a role for B7-2, expressed on T cells, in the down-modulation of T cell thereby controlling peripheral tolerance to other self-antigens. responses, including anti-T cell T cell responses (52) Thus, the up-regulation of B7-2 on M256-270-specific References T cells, induced upon recognition of self-hsp on APC, may well provide such T cells with a mechanism to control patho-
